Sonja Steinhauer
Overview
Explore the profile of Sonja Steinhauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garweg J, Steinhauer S
J Clin Med
. 2024 Mar;
13(6).
PMID: 38541760
Treatment cessation due to a dry retina has not been systematically addressed in diabetic macular edema (DME). In three out of four patients receiving 6 mg of brolucizumab in the...
2.
Lippert J, Smith G, Appenzeller S, Landwehr L, Prete A, Steinhauer S, et al.
Eur J Endocrinol
. 2024 Mar;
190(3):234-247.
PMID: 38451242
Objective: Adrenocortical carcinoma (ACC) is a rare aggressive cancer with heterogeneous behaviour. Disease surveillance relies on frequent imaging, which comes with significant radiation exposure. The aim of the study was...
3.
Warmington E, Smith G, Chortis V, Liang R, Lippert J, Steinhauer S, et al.
Endocr Connect
. 2023 Nov;
13(1).
PMID: 37992487
Adrenocortical carcinoma (ACC) is an aggressive malignancy with limited treatment options. Polo-like kinase 1 (PLK1) is a promising drug target; PLK1 inhibitors (PLK1i) have been investigated in solid cancers and...
4.
Lippert J, Altieri B, Morrison B, Steinhauer S, Smith G, Lorey A, et al.
J Clin Endocrinol Metab
. 2022 Aug;
107(10):2892-2899.
PMID: 35929659
Context: Adrenocortical carcinoma (ACC) is a rare aggressive disease with heterogeneous prognoses. Previous studies identified hypermethylation in the promoter region of specific genes to be associated with poor clinical outcome....
5.
Wons J, Pfister I, Anastasi S, Steinhauer S, Niderprim S, Garweg J
Clin Ophthalmol
. 2022 Jul;
16:2235-2243.
PMID: 35844664
Purpose: To compare the predictive value of macular perimetry and microperimetry for visual outcomes after vitrectomy with internal limiting membrane (ILM) peeling in full-thickness macular holes (MH). Methods: This retrospective,...
6.
Liang R, Weigand I, Lippert J, Kircher S, Altieri B, Steinhauer S, et al.
Front Endocrinol (Lausanne)
. 2020 May;
11:219.
PMID: 32373071
Adrenocortical carcinomas (ACC) are aggressive tumors with a heterogeneous prognosis and limited therapeutic options for advanced stages. This study aims to identify novel drug targets for a personalized treatment in...
7.
Lippert J, Appenzeller S, Liang R, Sbiera S, Kircher S, Altieri B, et al.
J Clin Endocrinol Metab
. 2018 Aug;
103(12):4511-4523.
PMID: 30113656
Context: Adrenocortical carcinoma (ACC) has a heterogeneous prognosis, and current medical therapies have limited efficacy in its advanced stages. Genome-wide multiomics studies identified molecular patterns associated with clinical outcome. Objective:...
8.
Laufs V, Altieri B, Sbiera S, Kircher S, Steinhauer S, Beuschlein F, et al.
Eur J Endocrinol
. 2017 Dec;
178(2):181-188.
PMID: 29187510
Objective: Platinum-based chemotherapy (PBC) is the most effective cytotoxic treatment for advanced adrenocortical carcinoma (ACC). Excision repair cross complementing group 1 (ERCC1) plays a critical role in the repair of...
9.
Henning J, Deutschbein T, Altieri B, Steinhauer S, Kircher S, Sbiera S, et al.
J Clin Endocrinol Metab
. 2017 Nov;
102(11):4323-4332.
PMID: 29092062
Context: Adrenocortical carcinoma (ACC) is rare and confers an unfavorable prognosis in advanced stages. Other than combination chemotherapy with cisplatin, etoposide, doxorubicin, and mitotane, the second- and third-line regimens are...
10.
Altieri B, Sbiera S, Della Casa S, Weigand I, Wild V, Steinhauer S, et al.
Oncotarget
. 2016 Dec;
8(6):9323-9338.
PMID: 28030838
Livin/BIRC7 is a member of the inhibitors of apoptosis proteins family, which are involved in tumor development through the inhibition of caspases. Aim was to investigate the expression of livin...